Cross-presentation of disialoganglioside GD3 to natural killer T cells

Journal of Experimental Medicine

Volumn 198, Issue 1, 2003, Pages 173-181

  Wu, Dianna Y ^a   Segal, Neil H ^a   Sidobre, Stephane ^b   Kronenberg, Mitchell ^b   Chapman, Paul B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

galactosylceramide; CD1d; Melanoma; NKT cell; Tetramer

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GANGLIOSIDE GD3; GANGLIOSIDE GM2; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; CYTOKINES; FEMALE; GALACTOSYLCERAMIDES; GANGLIOSIDES; HUMANS; IMMUNIZATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA;

EID: 0038152830     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030446     Document Type: Article

References (33)

1. Porcelli, S.A., and R.L. Modlin. 1999. The CD1 System: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297-329.
2. Moody, D.B., B.B. Reinhold, M.R. Guy, E.M. Beckman, D.E. Frederique, S.T. Furlong, S. Ye, V.N. Reinhold, P.A. Sieling, R.L. Modlin, G.S. Besra, and S.A. Porcelli. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:283-286.
3. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
4. Shamshiev, A., A. Donda, T.I. Prigozy, L. Mori, V. Chigorno, C.A. Benedict, L. Kappos, S. Sonnino, M. Kronenberg, and G. De Libero. 2000. The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity. 13:255-264.
5. Porcelli, S.A., B.W. Segelke, M. Sugita, I.A. Wilson, and M.B. Brenner. 1998. The CD1 family of lipid antigen-presenting molecules. Immunol. Today. 19:362-368.
6. Zeng, Z., A.R. Castano, B.W. Segelke, E.A. Stura, P.A. Peterson, and I.A. Wilson. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science. 277:339-345.
7. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
8. + and CD4-8-T cells in mice and humans. J. Exp. Med. 180:1097-1106.
9. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R. Bennink, and R.R. Brutkiewicz. 1995. CD1 recognition by mouse NK1 + T lymphocytes. Science. 268:863-865.
10. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895-1903.
11. Burdin, N., L. Brossay, Y. Koezuka, S.T. Smiley, M.J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg. 1998. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161:3271-3281.
12. D3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody. J. Exp. Med. 155:1133-1147.
13. Kusano, A., S. Ohta, K. Shitara, and N. Hanai. 1993. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Anticancer Research. 13:2207-2212.
14. Chapman, P.B., M. Lonberg, and A.N. Houghton. 1990. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship between avidity, effector functions, tumor targeting, and antitumor activity. Cancer Res. 50:1503-1509.
15. Vadhan-Raj, S., C. Cordon-Cardo, E.A. Carswell, D. Mintzer, L. Dantis, C. Duteau, M.A. Templeton, H.F. Oettgen, L.J. Old, and A.N. Houghton. 1988. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J. Clin. Oncol. 6:1636-1648.
16. Nasi, M., M. Meyers, P. Livingston, A. Houghton, and P. Chapman. 1997. Anti-melanoma effects of R24, a monoclonal antibody against GD3. Vaccine Research. 7:S155-S162.
17. Ladisch, S., H. Becker, and L. Ulsh. 1992. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim. Biophys. Acta. 1125:180-188.
18. Shamshiev, A., A. Donda, I. Carena, L. Mori, L. Kappos, and G. De Libero. 1999. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29:1667-1675.
19. Tallquist, M.D., T.J. Yun, and L.R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC-peptide complexes with high specificity. J. Exp. Med. 184:1017-1026.
20. Ruan, S., and K.O. Lloyd. 1992. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns. Cancer Res. 52:5725-5731.
21. Kina, T., K. Ikuta, E. Takayama, K. Wada, A.S. Majumdar, I.L. Weissman, and Y. Katsura. 2000. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109:280-287.
22. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
23. Segal, N.H., P. Pavlidis, W.S. Noble, C.R. Antonescu, A. Viale, U.V. Wesley, K. Busam, H. Gallardo, D. DeSantis, M.F. Brennan, et al. 2003. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J. Clin. Oncol. 21:1775-1781.
24. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521-1528.
25. Chapman, P.B., and A.N. Houghton. 1991. Induction of IgG antibodies against GD3 in rabbits by an anti-idiotypic monoclonal antibody. J. Clin. Invest. 88:186-192.
26. Ritter, G., E. Boosfeld, R. Adluri, M. Calves, H.F. Oettgen, L.J. Old, and P.O. Livingston. 1991. Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int. J. Cancer. 48:379-385.
27. McCaffery, M., T.-J. Yao, L. Williams, P.O. Livingston, A.N. Houghton, and P.B. Chapman. 1996. Enhanced immunogenicity of BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside when combined with adjuvant. Clin. Cancer Res. 2:679-686.
28. Ragupathi, G., M. Meyers, S. Adluri, L. Howard, L. Musselli, and P.O. Livingston. 2000. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int. J. Cancer. 85:659-666.
29. Crowe, N.Y., M.J. Smyth, and D.I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-127.
30. Sonoda, K.H., D.E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42-50.
31. H2 bias of natural killer T cells. Nature. 413:531-534.
32. H idiotope that results in specific homophilic binding and increased avidity for antigen. J. Immunol. 157:1582-1588.
33. Galli, G., S. Nuti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani. 2003. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197:1051-1057.